Dr. David Henry: Updated Recommendations for ESA Use in Patients With Cancer
Dr. David Henry: Updated Recommendations for ESA Use in Patients With Cancer
Interview by L Scott Zoeller
20110010
2011 Jan 10
Top Stories of 2010
Dr. David Henry: Updated Recommendations for ESA Use in Patients With Cancer
Top Stories of 2010. 2011 Jan 10, Interview by L Scott Zoeller
Abstract
Dr. David Henry is Clinical Professor of Medicine and Vice Chair, Department of Medicine at Pennsylvania Hospital; Pennsylvania Oncology Hematology Associates, Inc., Philadelphia, Pennsylvania. OncologySTAT: In your view, which development in cancer research that occurred in 2010 could have the most significant impact on oncology?Dr. Henry: My answer would have to be the treatment of chemotherapy-induced anemia (CIA).OncologySTAT: What specific changes in oncology have you observed or do you foresee...